Janux Therapeutics (JANX) EPS (Basic) (2020 - 2026)
Janux Therapeutics (JANX) posted quarterly EPS (Basic) of -$0.84 for Q1 2026, up 66.3% year-over-year from -$0.51 in Q1 2025, and down 63.62% quarter-over-quarter from -$0.52 in Q4 2025.
Powered by 
Analysis
Janux Therapeutics (JANX) EPS (Basic) (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported EPS (Basic) for 7 consecutive years, with -$0.84 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 66.3% year-over-year to -$0.84; the TTM figure through Mar 2026 stood at -$5.56 (up 57.54% YoY), while the FY2025 annual figure was -$2.31, up 71.15% from the prior year.
- EPS (Basic) fell to -$0.84 in Q1 2026 per JANX's latest filing, from -$0.52 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.27 in Q4 2023 and bottomed at -$6.25 in Q3 2024.
- Historically, EPS (Basic) has averaged -$1.96 across 5 years, with a median of -$1.31 in 2022.
- Annual changes were most pronounced in 2024 — EPS (Basic) slumped 972.57% — and 2026, when it surged 66.3%.
- Janux Therapeutics' EPS (Basic) stood at -$0.4 in 2022, then surged by 32.49% to -$0.27 in 2023, then sank by 40.79% to -$0.38 in 2024, then plunged by 37.07% to -$0.52 in 2025, then slumped by 63.62% to -$0.84 in 2026.
- Business Quant data shows JANX's EPS (Basic) at -$0.84 in Q1 2026, -$0.52 in Q4 2025, and -$2.11 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Janux Therapeutics | 1.27 Bn | 1.27 Bn | - | -0.35 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.35 |
| Mar 31, 2026 | -0.39 |
| Dec 31, 2025 | -0.52 |
| Sep 30, 2025 | -0.39 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.38 |
| Dec 31, 2024 | -0.38 |
| Sep 30, 2024 | -0.51 |
| Jun 30, 2024 | -0.11 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | -0.27 |
| Sep 30, 2023 | -0.25 |
| Jun 30, 2023 | -0.42 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | -0.39 |
| Sep 30, 2022 | -0.40 |
| Jun 30, 2022 | -0.41 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.57 |
| Sep 30, 2021 | -0.26 |